Becton, Dickinson and Company (BDX)

Healthcare

$183.75

+0.55%

nightly snapshot · 10/11/2026

ALPHASCORE™ · C+ · Neutral

ALPHASCORE

51

/ 100

C+

NEUTRAL

▲ 0 · 30D

KEY FUNDAMENTALS

P/E42.7

ROE6.6%

NET MARGIN7.7%

GROSS MARGIN45.4%

MKT CAP$50.05B

loading full analysis…

DAILY BRIEF

Becton, Dickinson and Company (Healthcare) records an AlphaScore of 51/100 as of 2026-10-11, earning a C+ grade and a Neutral signal. The firm notes a gross margin of 45.44% and a net margin of 7.68%. A notable strength is the solid revenue growth of 8.24%. Conversely, a significant risk is the low return on equity (ROE) of 6.61%. Evidence is limited exclusively to the provided snapshot.

Written 11/10/2026, 00:32:17 UTC · Snapshot 11/10/2026